A study published in June 2015 in the Journal of the American Medical Association (JAMA) determined that clinical trials on finasteride did not sufficiently report on Propecia side effects. Lead author Steven Belknap, of the Northwestern University Feinberg School of Medicine, said,
“People who take or prescribe the drug assume it’s safe, but there is insufficient information to make that judgment.”
In a JAMA Dermatology interview online, Thomas Moore, Senior Scientist, Drug Safety and Policy, Institute for Safe Medication Practices, said that “We know now, more than 20 years after [finasteride] was first approved, that it is unequivocally true that the drug impairs male sexual function. And we can see this in all our standard references: the package insert, the major textbooks. So the facts are clear. The question is, why didn’t they show up more clearly in the clinical trials?”
And another question: what took the feds so long to recognize that Propecia sexual dysfunction is not as rare as the Propecia manufacturer would have men with baldness issues believe? The Post-Finasteride Syndrome Foundation PFS was founded in 2012. It contains reports from health professionals dating back to 2010 warning about permanent finasteride sexual dysfunction, including Propecia impotence.
READ MORE PROPECIA LEGAL NEWS
If you have taken Propecia, you might want to visit PFSFoundation.org - the US National Institutes of Health did. The foundation has so far funded three research initiatives regarding PFS and provides patient-recruitment information on active clinical studies, published research, research goals and media reports about PFS. And if you are suffering from PFS, you might want to contact an experienced Propecia attorney.